aid: clarametyx-biosciences

name: Clarametyx Biosciences

description: Clarametyx Biosciences is a biopharmaceutical company focused on developing novel immune‑enabling therapies targeting bacterial biofilms
  that drive chronic respiratory diseases such as cystic fibrosis. The company advances its pipeline through pre‑clinical and early‑stage clinical
  programs, aiming to modify disease progression rather than merely alleviate symptoms. Recent announcements include positive topline data from
  a Phase 2a study of CMTX‑101 and significant Series A financing to accelerate development.

url: https://raw.githubusercontent.com/api-evangelist/clarametyx-biosciences/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-08 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-08'

modified: '2026-10-08'

tags:
- Respiratory Diseases
- Clinical Trials
- Drug Development
- Biofilms

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/clarametyx-biosciences-hosts.yml
- type: DomainSecurity
  url: security/clarametyx-biosciences-domain-security.yml
- type: Website
  url: https://clarametyx.com
- type: PrivacyPolicy
  url: https://clarametyx.com/privacy-policy/

apis: []

x-coverage:
  state: none
  reason: no-developer-program
  method: derived
  generated: '2026-10-08'
  generator: derive-coverage.py (pre-flight evidence)
  detail: the company publishes no developer documentation host and no machine-readable contract on its own domain
  evidence:
  - url: https://clarametyx.com
    status: 200
  - url: https://forgeglobal.com/clarametyx-biosciences_stock/
    status: 200
x-enrichment:
  date: '2026-10-08'
  status: enriched
  artifacts_added: 6
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local